BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30042232)

  • 1. The lateral meningocele syndrome mutation causes marked osteopenia in mice.
    Canalis E; Yu J; Schilling L; Yee SP; Zanotti S
    J Biol Chem; 2018 Sep; 293(36):14165-14177. PubMed ID: 30042232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An antibody to Notch3 reverses the skeletal phenotype of lateral meningocele syndrome in male mice.
    Yu J; Siebel CW; Schilling L; Canalis E
    J Cell Physiol; 2020 Jan; 235(1):210-220. PubMed ID: 31188489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense oligonucleotides targeting
    Canalis E; Grossman TR; Carrer M; Schilling L; Yu J
    J Biol Chem; 2020 Mar; 295(12):3952-3964. PubMed ID: 31992595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of antisense oligonucleotides to target Notch3 in skeletal cells.
    Canalis E; Carrer M; Eller T; Schilling L; Yu J
    PLoS One; 2022; 17(5):e0268225. PubMed ID: 35536858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of a NOTCH3 Lehman syndrome mutation in osteocytes causes osteopenia in male C57BL/6J mice.
    Canalis E; Yee SP; Economides AN; Schilling L; Yu J
    Bone; 2022 Sep; 162():116476. PubMed ID: 35760307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Notch3 in osteoblasts/osteocytes causes compartment-specific changes in bone remodeling.
    Canalis E; Zanotti S; Schilling L; Eller T; Yu J
    J Biol Chem; 2021; 296():100583. PubMed ID: 33774049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligonucleotides targeting a NOTCH3 mutation in male mice ameliorate the cortical osteopenia of lateral meningocele syndrome.
    Canalis E; Mocarska M; Schilling L; Jafar-Nejad P; Carrer M
    Bone; 2023 Dec; 177():116898. PubMed ID: 37704069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncating mutations in the last exon of NOTCH3 cause lateral meningocele syndrome.
    Gripp KW; Robbins KM; Sobreira NL; Witmer PD; Bird LM; Avela K; Makitie O; Alves D; Hogue JS; Zackai EH; Doheny KF; Stabley DL; Sol-Church K
    Am J Med Genet A; 2015 Feb; 167A(2):271-81. PubMed ID: 25394726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lateral meningocele (Lehman) syndrome: A child with a novel NOTCH3 mutation.
    Ejaz R; Qin W; Huang L; Blaser S; Tetreault M; Hartley T; Boycott KM; Carter MT;
    Am J Med Genet A; 2016 Apr; 170A(4):1070-5. PubMed ID: 26754023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome.
    Zanotti S; Yu J; Sanjay A; Schilling L; Schoenherr C; Economides AN; Canalis E
    J Biol Chem; 2017 Jul; 292(29):12232-12244. PubMed ID: 28592489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hairy and enhancer of split 1 is a primary effector of NOTCH2 signaling and induces osteoclast differentiation and function.
    Yu J; Schilling L; Eller T; Canalis E
    J Biol Chem; 2021 Dec; 297(6):101376. PubMed ID: 34742737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor α.
    Yu J; Canalis E
    J Biol Chem; 2019 Sep; 294(39):14203-14214. PubMed ID: 31371452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption.
    Canalis E; Schilling L; Yee SP; Lee SK; Zanotti S
    J Biol Chem; 2016 Jan; 291(4):1538-1551. PubMed ID: 26627824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice harboring a Hajdu Cheney Syndrome mutation are sensitized to osteoarthritis.
    Zanotti S; Yu J; Bridgewater D; Wolf JM; Canalis E
    Bone; 2018 Sep; 114():198-205. PubMed ID: 29940267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Gsα in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity.
    Fulzele K; Dedic C; Lai F; Bouxsein M; Lotinun S; Baron R; Divieti Pajevic P
    Bone; 2018 Dec; 117():138-148. PubMed ID: 30266511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone.
    Xiong J; Piemontese M; Onal M; Campbell J; Goellner JJ; Dusevich V; Bonewald L; Manolagas SC; O'Brien CA
    PLoS One; 2015; 10(9):e0138189. PubMed ID: 26393791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Skeleton of Lateral Meningocele Syndrome.
    Canalis E
    Front Genet; 2020; 11():620334. PubMed ID: 33519922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOTCH2 promotes osteoclast maturation and metabolism and modulates the transcriptome profile during osteoclastogenesis.
    Canalis E; Schilling L; Yu J; Denker E
    J Biol Chem; 2024 Feb; 300(2):105613. PubMed ID: 38159855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Antibody to Notch2 Reverses the Osteopenic Phenotype of Hajdu-Cheney Mutant Male Mice.
    Canalis E; Sanjay A; Yu J; Zanotti S
    Endocrinology; 2017 Apr; 158(4):730-742. PubMed ID: 28323963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling.
    Canalis E; Adams DJ; Boskey A; Parker K; Kranz L; Zanotti S
    J Biol Chem; 2013 Aug; 288(35):25614-25625. PubMed ID: 23884415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.